home · filing · 0000950170-23-026663
8-K filed June 6, 2023, 7:59 PM ET
ticker GDRX
CIK 0001809519
leadership
confidence high
sentiment neutral
materiality 0.50
GoodRx board member Jacqueline Kosecoff resigns; triggers Nasdaq audit committee non-compliance
GoodRx Holdings, Inc.
Jacqueline Kosecoff resigns from GoodRx Board, effective June 30, 2023, citing personal and professional commitments.
Resignation creates vacancy on Audit Committee, causing non-compliance with Nasdaq Rule 5605(c)(2)(A).
Company notified Nasdaq and will rely on cure period under Rule 5605(c)(4)(B) to regain compliance.
Kosecoff to remain as advisor to GoodRx after resignation; no disagreement with management.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Jacqueline Kosecoff
member of the Board
GDRX ·
GoodRx Holdings, Inc.
Effective 2023-06-30
Filed June 6, 2023, 7:59 PM ET
On June 5, 2023, Jacqueline Kosecoff notified the Company of her intent to resign as a member of the Board, effective June 30, 2023
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jacqueline Kosecoff resigned as member of the Board at GoodRx Holdings, Inc..
Action resigned
Role member of the Board
Exact text from the filing
On June 5, 2023, Jacqueline Kosecoff notified the Company of her intent to resign as a member of the Board, effective June 30, 2023
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-23-026663
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.